SCHEMBL9980388

SCHEMBL9980388

CNS(=O)(=O)c1ccc(N2CCCC2C)c(N)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 5/20 0.56
MAPT P10636 3/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
LMNA P02545 2/20 0.44
GFER P55789 1/20 0.43
SCN9A Q15858 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMARCA2 P51531 3/20 0.40
SMARCA4 P51532 3/20 0.40
PBRM1 Q86U86 3/20 0.40
NR1I2 O75469 2/20 0.40
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NR1H2 P55055 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12067173 1.00 TNNI3K (0.56) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL9980516 0.83 TNNI3K (0.56) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL12003831 0.83 TNNI3K (0.56) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL12067991 0.81 MAPT (0.66) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL12003680 0.81 TNNI3K (0.53) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL12067050 0.80 MAPT (0.46) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL9980429 0.79 GAA (0.54) MAPTKDM4EALDH1A1HPGDLMNA
SCHEMBL9980386 0.79 MAPT (0.45) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL2285629 0.78 ALDH1A1 (0.47) TNNI3KMAPTKDM4EALDH1A1HPGD
SCHEMBL12065552 0.78 MAPT (0.44) TNNI3KMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed